Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04414215 · ClinicalTrials.gov registry record · NA

Cognitive Training for Emotion Regulation in Psychotic Disorders

A NA study of Schizophrenia and Schizo Affective Disorder, sponsored by University of Georgia.

Recruiting
Registry status
NA
Development phase
70
Enrollment target
1
Study location

NCT04414215 is a NA study of Schizophrenia and Schizo Affective Disorder that is actively recruiting participants, run by University of Georgia. The registered enrollment target is 70 participants, below the 219-participant average among 315 other Schizophrenia trials with a reported enrollment target (68% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04414215, a NA study of Schizophrenia and Schizo Affective Disorder, is actively recruiting participants, sponsored by University of Georgia.

RECRUITING
Registry status
NA
Development phase
70 participants
Enrollment target
1
Study location

Study Summary

The current study examines the efficacy of a cognitive training intervention for improving emotion regulation in psychotic disorders. it is hypothesized that the cognitive training program will enhance prefrontal activation, leading to enhanced emotion regulation.

Interventions

  • BEHAVIORAL Emotional working memory training
  • BEHAVIORAL Placebo working memory training

Study Locations (1)

Georgia

  • University of Georgia - Athens

Trial Details

FieldValue
Enrollment Target 70 participants
Start Date 2020-06-01
Est. Completion 2029-12-31
Phase NA

Sponsor

University of Georgia

59 total trials

What the Registry Record Tells You About NCT04414215

The ClinicalTrials.gov registry entry for NCT04414215 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 219-participant average among 315 other Schizophrenia trials with a reported enrollment target (68% lower). The listed sponsor is University of Georgia, which has 59 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Schizophrenia appearing as the primary indexed condition, and to 2 interventions - of which Emotional working memory training is the first listed.

NCT04414215 reports 1 study location spanning 1 distinct geographic area - top geographies include Georgia.

Frequently Asked Questions

What is clinical trial NCT04414215 about?

NCT04414215 is a clinical study titled "Cognitive Training for Emotion Regulation in Psychotic Disorders". The current study examines the efficacy of a cognitive training intervention for improving emotion regulation in psychotic disorders. it is hypothesized that the cognitive training program will enhance prefrontal activation, leading to enhanced emotion regulation.

What is the current status of trial NCT04414215?

This trial is currently recruiting. It is a NA study. The enrollment target is 70 participants. The study started on 2020-06-01. Estimated completion is 2029-12-31.

What conditions does trial NCT04414215 study?

This clinical trial studies the following conditions: Schizophrenia, Schizo Affective Disorder.

What interventions are being tested in trial NCT04414215?

The interventions under investigation include: Emotional working memory training (BEHAVIORAL), Placebo working memory training (BEHAVIORAL).

Who is sponsoring clinical trial NCT04414215?

This trial is sponsored by University of Georgia, which has 59 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04414215 being conducted?

This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Schizophrenia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.